HC Wainwright & Co. Reiterates Buy on Dare Bioscience, Maintains $12 Price Target

Benzinga · 4d ago
HC Wainwright & Co. analyst Douglas Tsao reiterates Dare Bioscience (NASDAQ:DARE) with a Buy and maintains $12 price target.